These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 897837)

  • 41. Somatostatin stimulates glucagon secretion in ducks.
    Strosser MT; Cohen L; Harvey S; Mialhe P
    Diabetologia; 1980 Apr; 18(4):319-22. PubMed ID: 6106614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of selective insulin or glucagon deficiency on glucose turnover.
    Lickley HL; Ross GG; Vranic M
    Am J Physiol; 1979 Mar; 236(3):E255-62. PubMed ID: 426056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for a physiologic role of pancreatic glucagon in human glucose homeostasis: studies with somatostatin.
    Gerich JE; Lorenzi M; Hane S; Gustafson G; Guillemin R; Forsham PH
    Metabolism; 1975 Feb; 24(2):175-82. PubMed ID: 1113681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics.
    Trovati M; Massara F; Camanni F; Molinatti GM; Lorenzati R; Pagano GF
    J Endocrinol Invest; 1980; 3(2):189-92. PubMed ID: 6104680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The hypoglycaemic action of somatostatin in the anaesthetized dog.
    Blauth CI; Sönksen PH; Tompkins CV; Bloom SR
    Clin Endocrinol (Oxf); 1977 Jan; 6(1):17-25. PubMed ID: 844214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of cylic and linear forms of somatostatin in the inhibiton of growth hormone, insulin and glucagon Secretion.
    Leblanc H; Yen SS
    J Clin Endocrinol Metab; 1975 May; 40(5):906-8. PubMed ID: 1127098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Ala-2-D-Trp-8-D-Cys-14-somatostatin on the arginine induced release of insulin, GH and glucagon in normal men.
    Gonzalez-Barcena D; Mendoza F; Medina R; Coy DH; Murphy WA; Schally AV
    Endocr Res; 1984; 10(1):39-48. PubMed ID: 6146518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The integrated effect of adrenergic blockade on glucose, fatty acid, and glycerol kinetics: responses in the basal state and during hormonal control with somatostatin-hormonal infusion.
    Shaw JH; Wolfe RR
    J Surg Res; 1987 Mar; 42(3):257-72. PubMed ID: 2881026
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of somatostatin and two of its analogues on basal and arginine-stimulated insulin and glucagon secretion in the dog.
    Buchs A; Märki F; Keller U
    Regul Pept; 1982 Aug; 4(3):117-26. PubMed ID: 6127755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression and stimulation mechanisms controlling glucagon secretion in a case of islet-cell tumor producing glucagon, insulin, and gastrin.
    Tiengo A; Fedele D; Marchiori E; Nosadini R; Muggeo M
    Diabetes; 1976 May; 25(5):408-12. PubMed ID: 5326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glucagon immunoreactivity and antidiabetic action of somatostatin in the totally duodeno-pancreatectomized and gastrectomized human.
    Bringer J; Mirouze J; Marchal G; Pham TC; Luyckx A; Lefebvre P; Orsetti A
    Diabetes; 1981 Oct; 30(10):851-6. PubMed ID: 6115786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of somatostatin on plasma cyclic AMP and metabolic substrate responses to i.v. adrenaline and glucagon in humans.
    Nistrup Madsen S; Christensen SE; Hansen AP; Thode J
    Clin Endocrinol (Oxf); 1981 Nov; 15(5):431-7. PubMed ID: 6120054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of a long acting glucagon selective somatostatin analogue on plasma glucose, insulin and glucagon levels in the anaesthetized rat during arginine infusion.
    Lien E; Sarantakis D
    Diabetologia; 1979 Jul; 17(1):59-64. PubMed ID: 467854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Somatostatin and serum gastrin in normal subjects and in patients with pernicious anaemia, chronic liver and renal disease.
    Le Roith D; Vinik AI; Epstein S; Baron P; Olkenitzky MN; Pimstone BL
    S Afr Med J; 1975 Sep; 49(39):1601-4. PubMed ID: 1179234
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory effect of somatostatin on dibutyryl cyclic AMP-induced insulin and growth hormone release in human subjects.
    Peracchi M; Reschini E; Cantalamessa L; Catania A; Giustina G
    Metabolism; 1976 Mar; 25(3):321-8. PubMed ID: 175241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of somatostatin on basal levels of plasma growth hormone and insulin in acromegalics: dose-response studies and attempted total growth hormone suppression.
    Christensen SE; Nerup J; Hansen AP; Lundbaek K
    J Clin Endocrinol Metab; 1976 May; 42(5):839-45. PubMed ID: 773950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of changes in plasma levels of free fatty acids on plasma glucagon, insulin, and growth hormone in man.
    Hicks BH; Taylor CI; Vij SK; Pek S; Knopf RF; Floyd JC; Fajans SS
    Metabolism; 1977 Sep; 26(9):1011-23. PubMed ID: 895532
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhibition of pancreatic hormone secretion by somatostatin-28 and somatostatin-14 in man.
    Klaff LJ; Barron JL; Levitt NS; Ling N; Millar RP
    Acta Endocrinol (Copenh); 1983 Sep; 104(1):91-5. PubMed ID: 6137927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Malignant somatostatinoma: clinical features and metabolic studies.
    Axelrod L; Bush MA; Hirsch HJ; Loo SW
    J Clin Endocrinol Metab; 1981 May; 52(5):886-96. PubMed ID: 6112232
    [No Abstract]   [Full Text] [Related]  

  • 60. Insulin and glucagon response in patients with chronic pancreatitis.
    Ohneda A; Kai Y; Ishii S; Matsuda K; Horigome K
    Tohoku J Exp Med; 1976 Nov; 120(3):287-98. PubMed ID: 996852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.